Aims To identify the characteristics, treatment, and outcomes of contemporary patients with
valvular heart disease (VHD) in Europe, and to examine adherence to guidelines. Methods …

Importance Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common
presentation of coronavirus disease 2019 (COVID-19). Objective To determine whether …

Aims To analyse decision-making in elderly patients with severe, symptomatic aortic stenosis
(AS). Methods and results In the Euro Heart Survey on valvular heart disease, 216 patients …

Aim To identify the proportion and characteristics of patients with severe symptomatic mitral
regurgitation (MR) who are denied surgery. Methods and results In the Euro Heart Survey on …

Background: In clinical trials, at the group level, results are usually reported as mean and
standard deviation of the change in score, which is not meaningful for most readers. Objective: …

Objective To develop a disease activity index for patients with primary Sjögren's syndrome (SS):
the European League Against Rheumatism (EULAR) Sjögren's syndrome disease …

Objective To develop criteria for symptomatic improvement in patients with ankylosing spondylitis
(AS), using outcome domain data from placebo‐controlled clinical trials of nonsteroidal …

Objective. There is no effective treatment for patients with primary Sjögren’s syndrome (SS).
Since tumor necrosis factor (TNF) could be a key element in the pathogenesis of primary SS, …

Background: The patient acceptable symptom state (PASS) is the value beyond which patients
can consider themselves well. This concept can help in interpreting results of clinical trials…

Background Patients with COVID-19 pneumonia have an excess of inflammation and
increased concentrations of cytokines including interleukin-1 (IL-1). We aimed to determine …